Amy B. Cadwallader, PhD and AMA Council on Science and Public Health
Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients.
AMA J Ethics. 2022;24(5):E410-418. doi:
10.1001/amajethics.2022.410.